Sr. Medical Director, Gastrointestinal and Inflammation (Remote)

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

Job Description

About the role:

Join Takeda as a Senior Medical Director, Pharmacovigilance in Gastrointestinal and Inflammation (GI²). You will oversee medical safety activities and processes for assigned products, ensuring continuous assessment of safety profiles and benefit-risk of investigational and marketed compounds.

You will provide strategic, patient-focused leadership for medical safety, support asset strategies, and strengthen medical and scientific innovation. Timely escalation of safety issues to the Takeda Safety Board Chair is required. You will define and implement a vision for Patient Safety, enhance medical safety capabilities, and be a core member of company-wide Committees and Governance.

As part of the Patient Safety and Pharmacovigilance (PSPV) team, you will report to the Vice President, Therapeutic Area Head of Gastrointestinal and Inflammation PSPV. You may manage/oversee physicians and Health Care Professionals (HCPs) serving as Global Safety Leaders (GSL) and PV Scientists for a compound that is both in clinical development and marketed in the designated therapeutic area.

How you will contribute:

• May directly manage a group of GSLs and PV Scientists responsible for overseeing the medical safety profile for assigned products.

• Interacts with and influences colleagues from other functions to ensure the successful development, design and implementation of comprehensive safety and benefit-risk assessment strategies for products.

• Oversees signal detection and risk management activities for assigned products and ensures that development plans include comprehensive safety assessment plans.

• Flexible to support compounds/initiatives outside of primary therapeutic area(s) as directed by business and departmental needs

• Leads PSPV Safety Team (GST) and Safety Management Team (SMT) for assigned GI compounds and products.

• Represents the cross-functional program team as a product safety profile and risk mitigation expert for internal (e.g., Takeda Safety Board) and external (e.g., Independent Data Monitoring Committee) stakeholders.

• Manages cross-functional assessment of benefit-risk profile and communication of safety information for assigned compounds and products.

• Leads the interpretation of safety data from internal and external sources, assessment of ensuing scientific and medical implications, and communication of the impact of same both in terms of “go/no go” decisions or modification of development plan or study design, including potential impact on timeline or product labeling, ensuring the primacy of patient safety.

• Mentors GSLs and PV Scientists with respect to compounds in development and marketed drugs, safety monitoring and risk management assessment and analysis. 

• Supports cross-functional team evaluations in preparation for presentations to the Takeda Safety Board and similar forums. The Senior Medical Director will be a key player in the preparation and presentation of materials to the Takeda Safety Board and similar forums.

• Manages the reactive response to emerging safety signals.

• May perform the medical safety evaluation of projects for new business development opportunities (e.g., due diligence evaluations).

• Ensures high quality analyses of safety information, in support of safety update regulatory submissions, investigational and new drug applications and interactions with regulatory authorities worldwide.

• Assists the Global Medical Safety GI Therapeutic Area Head in assessing the implications of emerging